News

Wasabi Tripling As It Siphons Customers From AWS, Azure In $233 Billion Cloud Market

A case in point is Boston-based Wasabi Technologies, a provider of object storage services that compete with AWS’s S3 at 20% of the price. Whereas the industry grew at an average 31% rate in the most recent quarter, Wasabi’s revenues soared 5.5-fold between January 2019 and January 2020 and are expected to triple in 2020. Read more >>
Read more...

Myomo® Receives First Australian Insurance Authorization for MyoPro™

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that a Myomo-trained Orthotic & Prosthetic (“O&P”) practice in Australia has received its first insurance authorization to fit a patient with a custom MyoPro device. This is the first authorization following Myomo’s entry into Australia as part of its international expansion initiative. Read more >>
Read more...

Murray moves to Bryan to try out new glasses

"Benjamin Bruce Murray, “The eSight Guy,” is hoping to upgrade a lot more than just technology. Murray, of Melbern, is legally blind with optic nerve atrophy, but his first set of eSight 2 glasses in 2016 opened up the world of 20/20 vision and got him a job at Bryan’s WBNO/WQCT radio station. Read more >>
Read more...

Veteran Health Administration Expanding Homecare Pain Management Program with Sustained Acoustic Medicine (SAM) Ultrasound Patch Technology During COVID-19

Military veteran Dr. Ervin Rodriguez, who served as a First Sergeant in the United States Army, experienced a life-changing improvement in the state of multiple chronic soft-tissue injury sites after treating them with the Sustained Acoustic Medicine (SAM®) wearable, multi-hour, ultrasound device manufactured by ZetrOZ Systems in Trumbull, CT, USA. Read more >>
Read more...

Cannabis and Science

In the 1980s and 1990s, researchers identified cannabinoid receptors in humans (CB1 for THC and CB2 for CBD). What they were uncovering was the human body’s own endocannabinoid system (ECS). “It’s a system as ancient as our immune system and our central nervous system. They co-evolved and our endocannabinoid system acts as a bridge between the two,” says Yuval Cohen, CEO and Director of Corbus Pharmaceuticals. Read more >>
Read more...